{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Verapamil Hydrochloride is a prescription injectable medication (2.5 mg/mL) used intravenously to treat conditions like high blood pressure and certain heart rhythm issues by blocking calcium channels, helping relax blood vessels and improve blood flow. Manufactured by Gland Pharma Limited under ANDA214361. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Verapamil hydrochloride \u2014 ANDA 214361 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214361", "mediaType": "text/html", "title": "Verapamil hydrochloride"}], "identifier": "ANDA214361", "issued": "2016-09-16", "keyword": ["drug-safety", "public-health", "drug", "drug-information", "pharmaceuticals"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Verapamil hydrochloride"}